{
  "docId": "019de074-559c-76fa-9457-a7d91e9a06c5",
  "docSlug": "15199f0b497c4ef204a0760da27401b3",
  "documentTitle": "Dare Bioscience | Investor Presentation Deck | 54 slides",
  "authorId": "dare-bioscience",
  "authorName": "Daré Bioscience",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2938006,
  "pageNumber": 17,
  "pageCount": 54,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide uses a structured comparison format to frame the medical problem and the proposed solution.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-559c-76fa-9457-a7d91e9a06c5/17",
  "deckHref": "/decks/019de074-559c-76fa-9457-a7d91e9a06c5",
  "deckJsonHref": "/decks/019de074-559c-76fa-9457-a7d91e9a06c5.json",
  "deckAnchorHref": "/decks/019de074-559c-76fa-9457-a7d91e9a06c5#slide-17",
  "components": [
    {
      "bbox": {
        "h": 0.035,
        "w": 0.768,
        "x": 0.116,
        "y": 0.775
      },
      "kind": "callout",
      "text": "Daré Innovation: XACIATO™ (Clindamycin Phosphate) Vaginal Gel, 2%*",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "96251ab2-b699-44e4-8a13-be756e26d6b2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.185,
        "w": 0.928,
        "x": 0.036,
        "y": 0.403
      },
      "kind": "list",
      "text": "Limitations with current standards of care: Recurrent nature, systemic antibiotic preference issues, suboptimal cure rates (37-68%).",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "065125d7-07d3-469f-8db8-625069e0fa8a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.185,
        "w": 0.928,
        "x": 0.036,
        "y": 0.23
      },
      "kind": "list",
      "text": "Clinical Issue: Recurring infection, difficult to treat; affects ~21 million women; increases health risks.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b6c8c924-4fa1-4d99-af14-6b9282ee3f4b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.185,
        "w": 0.928,
        "x": 0.036,
        "y": 0.581
      },
      "kind": "list",
      "text": "Target Product Profile: Single dose, vaginal delivery, colorless/odorless, equivalent cure rates, clear labeling.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bdc8e1d9-c6ed-4da2-8f50-2cf124490260",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.705,
        "x": 0.045,
        "y": 0.815
      },
      "kind": "source-note",
      "text": "1. CDC stats; 2. Mayo Clinic; 3. Product data.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f96316de-4e65-4d6f-8882-e7c81b0da175",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.224,
        "x": 0.388,
        "y": 0.158
      },
      "kind": "title",
      "text": "Bacterial Vaginosis",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "71850433-3b9f-4c0a-ada9-776898ad0bc5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "9dbc7958-cf09-4be2-9208-0f690680e485",
      "evidence": "list/bullet: Limitations with current standards of care: Recurrent nature, systemic antibiotic preference issues, suboptimal cure rates (37-68%).",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "before-after-bridge",
      "slug": null,
      "matchId": "77a78f59-67b9-4ffa-830f-7b38d83d1394",
      "evidence": "The slide contrasts the current clinical problem/limitations with the target product profile solution.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 17,
      "from": 17,
      "beatId": "ec697af9-86c4-44cd-8770-2e06af882f4d",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "Slide 17 presents a clear problem statement for Bacterial Vaginosis",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 54,
      "from": 17,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "2cf418f8-2568-4e9a-bf9d-f55bdd0bfb9e",
      "evidence": "The deck implies that inaction in women's health has significant consequences",
      "position": 0,
      "objective": "What is the cost of inaction in women's health?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}